DAEWOONG PHARMACEUTICAL CO., LTD.
Patent Owner
Stats
- 27 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Feb 15, 2018 most recent publication
Details
- 27 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 138 Total Citation Count
- Feb 26, 1992 Earliest Filing
- 15 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0202,917 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SKIN RASHMay 14, 15Jul 20, 17[A61K]
2015/0050,333 PHARMACEUTICAL COMPOSITION COMPRISING OLMESARTAN MEDOXOMIL AND ROSUVASTATIN OR ITS SALTMar 22, 13Feb 19, 15[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9877922 Process of preparing microspheres for sustained release having improved dispersibility and syringeabilityApr 24, 09Jan 30, 18[A61K]
9782353 Film coated tablet containing choline alfoscerate and process for preparing the sameDec 15, 14Oct 10, 17[A61K]
9724336 Pharmaceutical composition for preventing or treating hyperlipidemiaNov 28, 12Aug 08, 17[A61K, C07D]
9717708 Process for preparing ertapenem-containing lyophilized formulationJul 28, 15Aug 01, 17[A61K]
9617216 Antifungal oxodihydropyridinecarbohydrazide derivativeOct 21, 14Apr 11, 17[A61K, C07D, A61P]
9486443 Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseasesNov 28, 12Nov 08, 16[A61K, C07D]
9376429 Sodium channel blockers, preparation method thereof and use thereofOct 15, 13Jun 28, 16[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8580848 Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereofExpiredJun 05, 12Nov 12, 13[A61K, C07D]
8507553 Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereofExpiredJun 05, 12Aug 13, 13[A61K, C07D]
8455542 Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereofExpiredJun 05, 12Jun 04, 13[A61K, C07D]
2012/0156,263 Ursodeoxycholic Acid-Synthetic Hydrotalcite-Eudragit Hybrid, Pharmaceutical Composition Containing the Same and Method for Preparing the SameAbandonedSep 10, 10Jun 21, 12[A61K, B29B, A61P]
2007/0264,341 Process of preparing microspheres for sustained release having improved dispersibility and syringeabilityAbandonedAug 29, 06Nov 15, 07[A61K]
7037491 Human thrombopoietin comprising glycosylation sited at residues 157 and 164ExpiredJan 26, 05May 02, 06[C07K]
2005/0186,280 Method for stabilizing a composition having a biologically active epidermal growth factor as an active ingredientAbandonedApr 25, 05Aug 25, 05[A61K]
2004/0029,965 Formulations for reducing or eliminating toxicity of enviromental hormones containing ursodeoxycholic acidAbandonedApr 01, 03Feb 12, 04[A61K]
2004/0022,855 Cored tablets comprising amoxicillin and clavulanateAbandonedJul 29, 03Feb 05, 04[A61K]
2003/0228,666 Novel human thrombopoietin muteinAbandonedMay 20, 03Dec 11, 03[C07H, C12P, C12N, C07K]
6541619 Fusion protein of hEGF and human angiogenin and process for preparing the sameExpiredJul 13, 00Apr 01, 03[A61K, C12N]
2003/0050,238 Stable composition comprising epidermal growth factor as an active ingredientAbandonedOct 04, 01Mar 13, 03[A61K]
5639878 Acyloxylation process for preparing 4-acyloxy-2-azetidinone derivativesExpiredJul 24, 95Jun 17, 97[C07D, C07B]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.